Disclosures for "Efficacy and Safety of Inebilizumab in Treating AQP4-Positive NMOSD Patients with Comorbid Autoimmune Diseases"
-
Mrs. Zhou has nothing to disclose.
-
Prof. Quan has nothing to disclose.
-
Dr. Li has received research support from the National Natural Science Foundation of China(NO.81901229).
-
Miss xuan has nothing to disclose.